The Eµ-hnRNP K Murine Model of Lymphoma: Novel Insights into the Role of hnRNP K in B-Cell Malignancies
Autor: | Prerna Malaney, Xiaorui Zhang, Marisa J.L. Aitken, Miguel Gallardo, Lauren E. Chan, Pedro Aguilar-Garrido, Maria Velasco-Estevez, Sean M. Post |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
0301 basic medicine
lcsh:Immunologic diseases. Allergy Lymphoma B-Cell RNA-binding protein mouse model Immunology lymphoma Review MYC Biology Animals Genetically Modified Heterogeneous-Nuclear Ribonucleoprotein K Proto-Oncogene Proteins c-myc B-cell malignancies 03 medical and health sciences 0302 clinical medicine Downregulation and upregulation medicine Animals Immunology and Allergy Genetic Predisposition to Disease B cell Ribonucleoprotein B-Lymphocytes Eµ-Hnrnpk Oncogene hnRNP K Cancer medicine.disease diffuse large B cell lymphoma Up-Regulation Lymphoma Gene Expression Regulation Neoplastic Disease Models Animal Cell Transformation Neoplastic Phenotype 030104 developmental biology medicine.anatomical_structure 030220 oncology & carcinogenesis Cancer research lcsh:RC581-607 Diffuse large B-cell lymphoma |
Zdroj: | Frontiers in Immunology, Vol 12 (2021) Frontiers in Immunology |
ISSN: | 1664-3224 |
Popis: | B-cell lymphomas are one of the most biologically and molecularly heterogeneous group of malignancies. The inherent complexity of this cancer subtype necessitates the development of appropriate animal model systems to characterize the disease with the ultimate objective of identifying effective therapies. In this article, we discuss a new driver of B-cell lymphomas – hnRNP K (heterogenous nuclear ribonucleoprotein K)—an RNA-binding protein. We introduce the Eµ-Hnrnpk mouse model, a murine model characterized by hnRNP K overexpression in B cells, which develops B-cell lymphomas with high penetrance. Molecular analysis of the disease developed in this model reveals an upregulation of the c-Myc oncogene via post-transcriptional and translational mechanisms underscoring the impact of non-genomic MYC activation in B-cell lymphomas. Finally, the transplantability of the disease developed in Eµ-Hnrnpk mice makes it a valuable pre-clinical platform for the assessment of novel therapeutics. |
Databáze: | OpenAIRE |
Externí odkaz: |